{"id":37465,"date":"2020-08-16T10:09:11","date_gmt":"2020-08-16T10:09:11","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=37465"},"modified":"2022-02-18T09:23:36","modified_gmt":"2022-02-18T09:23:36","slug":"committee-on-safety-in-medicines","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/","title":{"rendered":"Committee on safety in medicines"},"content":{"rendered":"<p>The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration.<\/p>\n<hr \/>\n<p>The official body which advises the British Government on the safety and quality of medicines.<\/p>\n<hr \/>\n<p>An independent advisory committee \u2014 launched in 1971 in the United Kingdom \u2014 composed of doctors, pharmacists and other specialists. It advises the Medicines &amp; Healthcare Regulatory Agency in the UK on the safety, efficacy and pharmaceutical quality of medicines for which licences are sought, and also reviews reports of adverse reactions to licensed medicines, including spontaneous \u2018Yellow Card\u2019 reports from doctors or pharmacists who suspect that a patient has suffered an adverse reaction from a medicine.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration. The official body which advises the British Government on the safety [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-37465","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Committee on safety in medicines - Definition of Committee on safety in medicines<\/title>\n<meta name=\"description\" content=\"The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration.The official body which advises the British Government on the safety and quality of medicines.An independent advisory committee \u2014 launched in 1971 in the United Kingdom \u2014 composed of doctors, pharmacists and other specialists. It advises the Medicines &amp; Healthcare Regulatory Agency in the UK on the safety, efficacy and pharmaceutical quality of medicines for which licences are sought, and also reviews reports of adverse reactions to licensed medicines, including spontaneous \u2018Yellow Card\u2019 reports from doctors or pharmacists who suspect that a patient has suffered an adverse reaction from a medicine.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Committee on safety in medicines - Definition of Committee on safety in medicines\" \/>\n<meta property=\"og:description\" content=\"The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration.The official body which advises the British Government on the safety and quality of medicines.An independent advisory committee \u2014 launched in 1971 in the United Kingdom \u2014 composed of doctors, pharmacists and other specialists. It advises the Medicines &amp; Healthcare Regulatory Agency in the UK on the safety, efficacy and pharmaceutical quality of medicines for which licences are sought, and also reviews reports of adverse reactions to licensed medicines, including spontaneous \u2018Yellow Card\u2019 reports from doctors or pharmacists who suspect that a patient has suffered an adverse reaction from a medicine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-16T10:09:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-18T09:23:36+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/\",\"name\":\"Committee on safety in medicines - Definition of Committee on safety in medicines\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-08-16T10:09:11+00:00\",\"dateModified\":\"2022-02-18T09:23:36+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration.The official body which advises the British Government on the safety and quality of medicines.An independent advisory committee \u2014 launched in 1971 in the United Kingdom \u2014 composed of doctors, pharmacists and other specialists. It advises the Medicines & Healthcare Regulatory Agency in the UK on the safety, efficacy and pharmaceutical quality of medicines for which licences are sought, and also reviews reports of adverse reactions to licensed medicines, including spontaneous \u2018Yellow Card\u2019 reports from doctors or pharmacists who suspect that a patient has suffered an adverse reaction from a medicine.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Committee on safety in medicines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Committee on safety in medicines - Definition of Committee on safety in medicines","description":"The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration.The official body which advises the British Government on the safety and quality of medicines.An independent advisory committee \u2014 launched in 1971 in the United Kingdom \u2014 composed of doctors, pharmacists and other specialists. It advises the Medicines & Healthcare Regulatory Agency in the UK on the safety, efficacy and pharmaceutical quality of medicines for which licences are sought, and also reviews reports of adverse reactions to licensed medicines, including spontaneous \u2018Yellow Card\u2019 reports from doctors or pharmacists who suspect that a patient has suffered an adverse reaction from a medicine.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/","og_locale":"en_US","og_type":"article","og_title":"Committee on safety in medicines - Definition of Committee on safety in medicines","og_description":"The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration.The official body which advises the British Government on the safety and quality of medicines.An independent advisory committee \u2014 launched in 1971 in the United Kingdom \u2014 composed of doctors, pharmacists and other specialists. It advises the Medicines & Healthcare Regulatory Agency in the UK on the safety, efficacy and pharmaceutical quality of medicines for which licences are sought, and also reviews reports of adverse reactions to licensed medicines, including spontaneous \u2018Yellow Card\u2019 reports from doctors or pharmacists who suspect that a patient has suffered an adverse reaction from a medicine.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/","og_site_name":"Glossary","article_published_time":"2020-08-16T10:09:11+00:00","article_modified_time":"2022-02-18T09:23:36+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/","name":"Committee on safety in medicines - Definition of Committee on safety in medicines","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-08-16T10:09:11+00:00","dateModified":"2022-02-18T09:23:36+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The British Government agency that must approve new pharmaceutical products for sale within the United Kingdom. In concert with the Medicines Control Agency (MCA), it regulates all pharmaceutical products in the United Kingdom. It is the equivalent of the U.S. Food and Drug Administration.The official body which advises the British Government on the safety and quality of medicines.An independent advisory committee \u2014 launched in 1971 in the United Kingdom \u2014 composed of doctors, pharmacists and other specialists. It advises the Medicines & Healthcare Regulatory Agency in the UK on the safety, efficacy and pharmaceutical quality of medicines for which licences are sought, and also reviews reports of adverse reactions to licensed medicines, including spontaneous \u2018Yellow Card\u2019 reports from doctors or pharmacists who suspect that a patient has suffered an adverse reaction from a medicine.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/committee-on-safety-in-medicines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Committee on safety in medicines"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/37465","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=37465"}],"version-history":[{"count":4,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/37465\/revisions"}],"predecessor-version":[{"id":146718,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/37465\/revisions\/146718"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=37465"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=37465"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=37465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}